Comparison of incidence, rate and length of all-cause hospital admissions between adults with normoglycaemia, impaired fasting glucose and diabetes: a retrospective cohort study in Geelong, Australia.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
    • Publication Information:
      Original Publication: [London] : BMJ Publishing Group Ltd, 2011-
    • Subject Terms:
      Diabetes Mellitus, Type 2/*epidemiology ; Hospitalization/*statistics & numerical data ; Prediabetic State/*blood ; Prediabetic State/*epidemiology; Adult ; Aged ; Aged, 80 and over ; Australia ; Blood Glucose/analysis ; Female ; Humans ; Hypoglycemic Agents/therapeutic use ; Incidence ; Logistic Models ; Male ; Middle Aged ; Prediabetic State/drug therapy ; Retrospective Studies ; Risk Factors ; Young Adult
    • Abstract:
      Objective: To determine whether adults with normoglycaemia, impaired fasting glucose (IFG) and diabetes differed according to the incidence, rate, length and primary reasons for hospital admission.
      Design: Retrospective cohort study.
      Setting: Barwon Statistical Division, Geelong, Australia.
      Participants: Cohort included 971 men and 924 women, aged 20+ years, participating in the Geelong Osteoporosis Study. Glycaemic status was assessed at cohort entry using fasting plasma glucose, use of antihyperglycaemic medication and/or self-report.
      Primary and Secondary Outcome Measures: Primary outcome measure was any admission to the major tertiary public hospital in the study region over the follow-up period. Secondary outcome measures were admission rate and length (days).
      Results: Over a median follow-up of 7.4 years (IQR 5.3-9.6), participants with diabetes, compared with those with normoglycaemia, were two times as likely to be hospitalised (OR 2.07, 95% CI 1.42 to 3.02), had a higher admission rate (incidence rate ratio 1.61, 95% CI 1.17 to 2.23) and longer hospital stay (third quartile difference 7.7, 95% CI 1.3 to 14.1 and ninth decile difference 16.2, 95% CI 4.2 to 28.3). IFG group was similar to normoglycaemia for the incidence, rate and length of admission. Cardiovascular disease-related diagnoses were the most common primary reasons for hospitalisation across all glycaemic categories.
      Conclusions: Our results show increased incidence, rate and length of all-cause hospital admission in adults with diabetes as compared with normoglycaemia; however, we did not detect any associations for IFG. Interventions should focus on preventing IFG-to-diabetes progression and reducing cardiovascular risk in IFG and diabetes.
      Competing Interests: Competing interests: None declared.
      (© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)
    • References:
      Diabet Med. 2015 Jan;32(1):133-40. (PMID: 25131861)
      BMC Health Serv Res. 2013 Nov 06;13:466. (PMID: 24195746)
      Diabet Med. 1998 Jul;15(7):539-53. (PMID: 9686693)
      Diabetes Res Clin Pract. 2007 Dec;78(3):360-8. (PMID: 17532084)
      Value Health. 2009 Mar-Apr;12(2):267-72. (PMID: 20667061)
      Diabetes Res Clin Pract. 2006 Sep;73(3):260-7. (PMID: 16504336)
      Aust N Z J Public Health. 2006 Dec;30(6):562-6. (PMID: 17209274)
      N Engl J Med. 2003 Jan 30;348(5):383-93. (PMID: 12556541)
      Lancet. 1998 Sep 12;352(9131):837-53. (PMID: 9742976)
      Diabetes Care. 2003 May;26(5):1344-9. (PMID: 12716786)
      Health Aff (Millwood). 1993 Spring;12(1):162-73. (PMID: 8509018)
      BMC Public Health. 2013 Mar 21;13:252. (PMID: 23517376)
      JAMA. 2004 Nov 24;292(20):2495-9. (PMID: 15562129)
      Diabetes Care. 1994 Nov;17(11):1320-9. (PMID: 7821174)
      PLoS One. 2015 Mar 04;10(3):e0118599. (PMID: 25739093)
      BMC Health Serv Res. 2015 Jan 22;15:12. (PMID: 25609196)
      BMC Health Serv Res. 2006 Jul 04;6:84. (PMID: 16820048)
      J Pediatr. 1994 Aug;125(2):177-88. (PMID: 8040759)
      Int J Epidemiol. 2012 Dec;41(6):1565-75. (PMID: 23283714)
      Diabet Med. 2002 Sep;19(9):708-23. (PMID: 12207806)
      J Clin Epidemiol. 2004 Nov;57(11):1196-201. (PMID: 15567637)
      Diabetes Care. 2000 Dec;23(12):1774-9. (PMID: 11128351)
      Aust N Z J Psychiatry. 2010 Oct;44(10):946-51. (PMID: 20932209)
      N Engl J Med. 2002 Feb 7;346(6):393-403. (PMID: 11832527)
      Int J Clin Pract. 2014 Jan;68(1):40-8. (PMID: 24112108)
      Diabetes Care. 2007 Mar;30(3):753-9. (PMID: 17327355)
      J Diabetes Res. 2015;2015:373762. (PMID: 26273669)
      Dis Manag. 2007 Dec;10(6):347-55. (PMID: 18163863)
    • Contributed Indexing:
      Keywords: diabetes mellitus; health service usage; hospitalisation; impaired fasting glucose
    • Accession Number:
      0 (Blood Glucose)
      0 (Hypoglycemic Agents)
    • Publication Date:
      Date Created: 20180326 Date Completed: 20180913 Latest Revision: 20190202
    • Publication Date:
      20221213
    • Accession Number:
      PMC5875593
    • Accession Number:
      10.1136/bmjopen-2017-020346
    • Accession Number:
      29574446